Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project

Fig. 2

Changes in number of psychotropics other than main drugs

(A) Result of subjects with schizophrenia: The Mono_poly group was prescribed a significantly higher number of psychotropics other than main drugs than the mono_mono group. The Poly_mono group was prescribed a significantly lower number of psychotropics other than the main drugs than the poly_poly group

(B) Result of subjects with MDD: The Poly_mono group was prescribed more antipsychotics than the poly_poly group

*1: chi-squared test

MDD, major depressive disorder, mono_mono, antipsychotics/antidepressants monotherapy at admission and discharge; mono_poly, antipsychotics/antidepressant monotherapy at admission and polypharmacy at discharge; poly_mono, antipsychotics/antidepressants polypharmacy at admission and monotherapy at discharge; poly_poly, antipsychotics/antidepressants polypharmacy at admission and at discharg

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us